Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Goldenberg

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Diabetes Research and Clinical Practice|October 5, 2024
Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1William Polonsky, Malik Benamar, Lisbeth Carstensen, et al.
Canadian Journal of Diabetes|February 24, 2023
Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional StudyAlice Y Y Cheng, Stewart Harris, Iris Krawchenko, et al.
Diabetes, Obesity & Metabolism|March 4, 2017
Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetesGuillermo E Umpierrez, David O'Neal, Andres DiGenio, et al.
Diabetes, Obesity & Metabolism|June 12, 2018
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE StudyPaola Fioretto, Stefano Del Prato, John B Buse, et al.
Diabetes, Obesity & Metabolism|January 18, 2017
Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapyRonald Goldenberg, Ira Gantz, Paula J Andryuk, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 18, 2020
Evaluating time to treatment and in-hospital outcomes of pulmonary embolism response teamsClay P Wiske, Chen Shen, Nancy Amoroso, et al.
The Annals of Pharmacotherapy|May 20, 2022
The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress SyndromeAlyson Katz, Diana Altshuler, John Papadopoulos, et al.
The Annals of Thoracic Surgery|April 28, 2020
Novel Percutaneous Tracheostomy for Critically Ill Patients With COVID-19Luis Angel, Zachary N Kon, Stephanie H Chang, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|November 13, 2020
Thrombosis at hospital presentation in patients with and without coronavirus disease 2019Shari B Brosnahan, Nathaniel R Smilowitz, Nancy E Amoroso, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 25, 2018
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 DiabetesLori Berard, Noreen Antonishyn, Kathryn Arcudi, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Diabetes Research and Clinical Practice|October 5, 2024
Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1William Polonsky, Malik Benamar, Lisbeth Carstensen, et al.
Canadian Journal of Diabetes|February 24, 2023
Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional StudyAlice Y Y Cheng, Stewart Harris, Iris Krawchenko, et al.
Diabetes, Obesity & Metabolism|March 4, 2017
Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetesGuillermo E Umpierrez, David O'Neal, Andres DiGenio, et al.
Diabetes, Obesity & Metabolism|June 12, 2018
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE StudyPaola Fioretto, Stefano Del Prato, John B Buse, et al.
Diabetes, Obesity & Metabolism|January 18, 2017
Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapyRonald Goldenberg, Ira Gantz, Paula J Andryuk, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 18, 2020
Evaluating time to treatment and in-hospital outcomes of pulmonary embolism response teamsClay P Wiske, Chen Shen, Nancy Amoroso, et al.
The Annals of Pharmacotherapy|May 20, 2022
The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress SyndromeAlyson Katz, Diana Altshuler, John Papadopoulos, et al.
The Annals of Thoracic Surgery|April 28, 2020
Novel Percutaneous Tracheostomy for Critically Ill Patients With COVID-19Luis Angel, Zachary N Kon, Stephanie H Chang, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|November 13, 2020
Thrombosis at hospital presentation in patients with and without coronavirus disease 2019Shari B Brosnahan, Nathaniel R Smilowitz, Nancy E Amoroso, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 25, 2018
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 DiabetesLori Berard, Noreen Antonishyn, Kathryn Arcudi, et al.
Pageof 5